This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser.
Print Document
Reports
Cover
Statements
Consolidated Balance Sheets
Consolidated Balance Sheets (Parenthetical)
Consolidated Statements of Operations and Comprehensive (Loss) Income
Consolidated Statements of Stockholders’ Equity
Consolidated Statements of Cash Flows
Reports
Organization and Significant Accounting Policies
Collaboration and License Agreements
Balance Sheet Accounts
Investments
Intangible Assets
Stockholders' Equity
Commitments and Contingencies
Leases
Stock-Based Compensation
Fair Value Measurements
Liability Related to the Sale of Future Royalties
Net Loss Per Share
Pay vs Performance Disclosure
Insider Trading Arrangements
Accounting Policies
Organization and Significant Accounting Policies (Policies)
Tables
Organization and Significant Accounting Policies (Tables)
Collaboration and License Agreements (Tables)
Balance Sheet Accounts (Tables)
Investments (Tables)
Intangible Assets (Tables)
Stockholders' Equity (Tables)
Leases (Tables)
Stock-Based Compensation (Tables)
Fair Value Measurements (Tables)
Liability Related to the Sale of Future Royalties (Tables)
Net Loss Per Share (Tables)
Details
Organization and Significant Accounting Policies - Narrative (Detail)
Collaboration and License Agreements - Revenue (Details)
Collaboration and License Agreements - Receivables and Contract Liabilities (Details)
Collaboration and License Agreements - Glaxosmithkline Intellectual Property (No. 3) Limited (Details)
Collaboration and License Agreements - Horizon Therapeutics Ireland DAC (Details)
Collaboration and License Agreements - Takeda Pharmaceutical Company Limited (Details)
Collaboration and License Agreements - Amgen, Inc (Details)
Collaboration and License Agreements - Visirna Therapeutics, Inc. (Details)
Balance Sheet Accounts - Summary of Property and Equipment (Detail)
Balance Sheet Accounts - Accrued Expenses (Details)
Investments - Summary of Short-term, Long-term Investments and Marketable Securities (Details)
Intangible Assets - Schedule of Intangible Assets (Details)
Intangible Assets - Expected Future Amortization (Details)
Stockholders' Equity (Details)
Commitments and Contingencies - Narrative (Detail)
Leases - Narrative (Details)
Leases - Components of Lease Assets and Liabilities (Details)
Leases - Summary of Maturities of Operating Lease Liabilities on an Undiscounted Basis (Details)
Leases - Supplemental Cash Flow and Other Information Related to Leases (Details)
Stock-Based Compensation - Narrative (Details)
Stock-Based Compensation - Summary of Granted and Outstanding Shares (Details)
Stock-Based Compensation - Expenses Included in Operating Expenses (Details)
Stock-Based Compensation - Summarize Information about Stock Options (Details)
Stock-Based Compensation - Summary of RSUs Activity (Details)
Fair Value Measurements - Fair Value Measurements for Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)
Liability Related to the Sale of Future Royalties - Narrative (Details)
Liability Related to the Sale of Future Royalties - Activity (Details)
Net Loss Per Share - Basic and Diluted Net Loss Per Share (Details)
Net Loss Per Share - Antidulitive (Details)
All Reports